Zobrazeno 1 - 10
of 107
pro vyhledávání: '"M. Puntous"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A, Damais-Cepitelli, S, Leo-Kodeli, V, Lovi, H, Gouëzec, B, Lassale, L, Augey, E, Berger, V, Betbèze, V, Bourcier, G, Daurat, S, Ducroz, C, Huchet, C, Le Niger, S, Pujol, M, Puntous
Publikováno v:
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 25(4)
One of the tasks of haemovigilance correspondents in Health Institutions (HI) is to reduce the destruction of labile blood components (LBC). The objective of this study was to analyse in depth, five years after a first multicentric study, the causes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ea32d3f2bb1b23f51d309c19bd7b7f72
https://pubmed.ncbi.nlm.nih.gov/30145111
https://pubmed.ncbi.nlm.nih.gov/30145111
Autor:
C, Le Niger, C, André, V, Bourcier, L, Augey, A, Bazin, E, Berger, V, Betbeze, A, Damais-Cepitelli, G, Daurat, E, De Meyer, S, Ducroz, H, Gouezec, C, Huchet, B, Lassale, S, Leo-Kodeli, V, Lovi, M, Puntous, S, Pujol, P, Renom, C, Rieux
Publikováno v:
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 25(1)
The decision of November 6th, 2006 defining the principles of best practices recommends that posttransfusional red cell alloantibodies research is performed after one to three months after. In the University hospital of Brest, the haemovigilance unit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a40f608d7c287bcdd8ea3a1965801e13
https://pubmed.ncbi.nlm.nih.gov/29273503
https://pubmed.ncbi.nlm.nih.gov/29273503
Autor:
M Puntous, H Mazaré, D Breilh, M. Megne Wabo, Aude Berroneau, S Djabarouti, V. Servant, F Xuereb
Publikováno v:
General management.
Background Blood derived medicines (BDM) need, as a result of their status, strict and obligatory traceability at each step of their circuit. Administration traceability for BDM has to be kept for 40 years at the pharmacy. However, care teams do not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2323d95ef36491b5fbf7dfccf791e05
https://doi.org/10.1136/ejhpharm-2017-000640.381
https://doi.org/10.1136/ejhpharm-2017-000640.381
Autor:
V. Servant, D Breilh, Aude Berroneau, M Puntous, F Xuereb, S Djabarouti, H Mazaré, M. Megne Wabo
Publikováno v:
General management.
Background Blood derived medicines (BDM) require close monitoring because of their theoretical infectious risk. However, clinical teams experience difficulties applying regulations and numerous dysfunctions are identified daily. Purpose We wished to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ea484b73130898798ea1f1dc96505c9
https://doi.org/10.1136/ejhpharm-2017-000640.380
https://doi.org/10.1136/ejhpharm-2017-000640.380
Publikováno v:
IRBM. 30:S31-S34
Resume Au cours d’un acte de chirurgie cardiaque avec circulation extracorporelle (CEC), les lesions chirurgicales consecutives a l’acte de dissection et le contact du sang avec les surfaces thrombogenes entrainent une activation de l’hemostase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::711d4ef3dad7331f25820c322935c2f9
https://doi.org/10.1016/s1959-0318(09)74601-9
https://doi.org/10.1016/s1959-0318(09)74601-9
Publikováno v:
Annales Françaises d'Anesthésie et de Réanimation. 15:1219-1229
Resume La mise sur le marche de nouveaux medicaments comme l'erythropoietine recombinante (rHu EPO) modifie les strategies transfusionnelles habituelles. Ainsi, les besoins transfusionnels peuvent etre reduits par la prescription preoperatoire de rHu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90f20bf6b180552a14d7ea5fc62f3abe
https://doi.org/10.1016/s0750-7658(97)85883-2
https://doi.org/10.1016/s0750-7658(97)85883-2
Autor:
A. Sauvage, E. Signac, S. Pujol, I. Roger, V. Moisset, M.C. Dubois, M. Puntous, Vanessa Augis
Publikováno v:
Transfusion Clinique et Biologique. 23:282
En 2015, l’unite de securite transfusionnelle et d’hemovigilance (USTH) du CHU de Bordeaux a recense et analyse 12 transfusions inappropriees : 6 transfusions de produits perimes, 4 transfusions destinees a un autre patient, une transfusion ne re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a5ba0f5d1821919a97e082edfb2303b
https://doi.org/10.1016/j.tracli.2016.08.040
https://doi.org/10.1016/j.tracli.2016.08.040
Autor:
M. Puntous, Jean-Michel Boiron, G. Vezon, A.M. Ferrer, G. Marit, C. Fabères, P. Bernard, A. Broustet, C. Foures, Josy Reiffers, Pascale Cony-Makhoul
Publikováno v:
Journal of Hematotherapy. 3:185-191
We retrospectively studied the factors affecting the rate of hematopoietic reconstitution (HR) in 118 patients with hematological malignancies who underwent peripheral blood progenitor cell (PBPC) transplantation at a single institution. The patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::368956d3202d15f97f51af0d82cc616b
https://doi.org/10.1089/scd.1.1994.3.185
https://doi.org/10.1089/scd.1.1994.3.185
Autor:
Y. Gloinec, C. Fratti, A. Sauvage, E. Signac, J.M. Dubois, V. Moisset, S. Pujol, I. Roger, M. Mage, M.C. Dubois, P. Fialon, M. Puntous
Publikováno v:
Transfusion Clinique et Biologique. 21:255-256
Particulierement impliquee dans l’enseignement transfusionnel des professionnels infirmiers, notre equipe (Unite de securite transfusionnelle et d’Hemovigilance du CHU de Bordeaux) a mis en place depuis plusieurs annees, avec trois IFSI partenair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dba73464ae4d4b451dec4edea58978c
https://doi.org/10.1016/j.tracli.2014.08.040
https://doi.org/10.1016/j.tracli.2014.08.040